(Q84474916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Dabigatran in atrial fibrillation: pharmacology and clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

1

Michael D Ezekowitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Rangadham Nagarakanti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

30 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

Journal of Interventional Cardiac Electrophysiology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

173-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10840-011-9593-x

6 February 2020

exact match

0 references

cites work

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey

1 reference

12 December 2020

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

1 reference

12 December 2020

Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.

1 reference

12 December 2020

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

1 reference

12 December 2020

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

12 December 2020

Newly identified events in the RE-LY trial

1 reference

12 December 2020

"Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients

1 reference

12 December 2020

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

12 December 2020

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

1 reference

12 December 2020

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population

1 reference

12 December 2020

Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients.

1 reference

12 December 2020

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

12 December 2020

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

12 December 2020

Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice

1 reference

12 December 2020

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Hepatic findings in long-term clinical trials of ximelagatran

1 reference

12 December 2020

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

12 December 2020

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

12 December 2020

Direct thrombin inhibitors

1 reference

12 December 2020

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

1 reference

12 December 2020

Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

1 reference

12 December 2020

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

12 December 2020

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

12 December 2020

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

12 December 2020

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

12 December 2020

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

12 December 2020

Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion

1 reference

12 December 2020

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

12 December 2020

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation

1 reference

12 December 2020

10.1007/S10840-011-9593-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717198%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference